European heart journal
-
European heart journal · Apr 2016
Randomized Controlled Trial Multicenter Study Comparative StudyThe effect of cangrelor and access site on ischaemic and bleeding events: insights from CHAMPION PHOENIX.
To assess whether the use of the femoral or radial approach for percutaneous coronary intervention (PCI) interacted with the efficacy and safety of cangrelor, an intravenous P2Y12 inhibitor, in CHAMPION PHOENIX. ⋯ http://www.clinicaltrials.gov identifier: NCT01156571.